12 Questions with Faruk Uzman
Find out more about Faruk Uzman, VP EMEA at Boston Scientific, in a new 12 Questions With.
FDA kicks off review of Roche's Gazyva for wider lupus use
Roche could be just months away from an FDA approval of Gazyva as the first anti-CD20 therapy for systemic lupus erythematosus.
Italy leads the way on child genetic disease diagnosis
A scheme to hasten the diagnosis of children with genetic disorders is achieving strong results and could be a template for national health systems.
From promise to practice: What must happen next for genetic ...
The systems needed to deliver GBT testing consistently across the NHS are still evolving to keep pace with these scientific advances.
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
Axtria Acquires Conexus Solutions, Uniting Agentic AI and CR...
Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, today announced the acquisition of Conexus Solutions
PHARMAP 2026: From Vendors to Strategic Partners
Strategic Partnerships at PHARMAP 2026 – Big Pharma’s Shift Toward CDMOs and CMOs
WOMA 2026: Steering the Future of Pharma Strategy
The WOMA Forum is not merely a conference. It's a convergence point for decision-makers
6th mRNA‑Based Therapeutics Summit
Advancing mRNA's Therapeutic Potential to Combat All Diseases
Agentic AI is Ready. Most Pharma Organizations Are Not
Axtria Ignite 2026 returns June 10–11 in Princeton, New Jersey